Management of cystic fibrosis in adults

Masel, Philip (2012) Management of cystic fibrosis in adults. Australian Prescriber, 35 4: 118-121.

Attached Files (Some files may be inaccessible until you login with your UQ eSpace credentials)
Name Description MIMEType Size Downloads
UQ282027_OA.pdf Full text (open access) application/pdf 98.25KB 4

Author Masel, Philip
Title Management of cystic fibrosis in adults
Journal name Australian Prescriber   Check publisher's open access policy
ISSN 0312-8008
1839-3942
Publication date 2012-08
Sub-type Article (original research)
Open Access Status File (Publisher version)
Volume 35
Issue 4
Start page 118
End page 121
Total pages 4
Place of publication Deakin, ACT, Australia
Publisher National Prescribing Service
Collection year 2013
Language eng
Formatted abstract
Cystic fibrosis is the most common lethal autosomal recessive disease. Mutations in a
membrane protein cause secretions such as mucus and digestive juices to be abnormally
thick and sticky.

Respiratory symptoms tend to dominate the course of the disease but other complications include gastrointestinal disorders, male infertility, osteoporosis, diabetes and rhinosinusitis.

Due to improved treatments in childhood, the life expectancy of patients with cystic fibrosis has increased. Doctors are now more likely to encounter adults with this disease so being aware of current and emerging therapies used in their management is important.
Keyword Antibiotic
Corticosteroids
Mucolytics
Q-Index Code C1
Q-Index Status Confirmed Code
Institutional Status UQ

Document type: Journal Article
Sub-type: Article (original research)
Collections: Official 2013 Collection
School of Medicine Publications
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 0 times in Thomson Reuters Web of Science Article
Scopus Citation Count Cited 0 times in Scopus Article
Google Scholar Search Google Scholar
Created: Mon, 17 Sep 2012, 11:10:54 EST by Matthew Lamb on behalf of School of Medicine